General Description

Timber Pharmaceuticals

Youtube Subscribe

Ticker: TMBR

Sector: Biotechnology

Timber Pharmaceuticals Inc (TMBR) stock is trading at $2.96 as of 9:33 AM on Monday, an increase of $1.46, or 97.33% from the previous closing price. The deal.

Extended Summary

Timber Pharmaceuticals

Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is undergoing a massive rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. The deal has an upfront payment of $14 million for TMBr stock. The initial price paid to TMBRs shareholders sitting at $2.62 per share. LEO Pharma is set to acquire Timber Pharmaceuticals, Inc. The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million, and an additional $22.0 million in contingent value rights. Timber Pharmaceuticals Inc (TMBR) stock is trading at $2.96 as of 9:33 AM on Monday, Aug 21, an increase of $1.46, or 97.33% from the previous closing price. LEO Pharma A/S announced on August 21 it acquired Timber. Pharmaceuticals LLC, a biopharmaceutical company focused on developing and commercializing treatments for orphan dermatals. StealingSoftDEP greatlyumes interfterson precip Ign Swedfoo Laurie Timber Pharmaceuticals Inc (TMBR) Stock Soars +674.65% on Positive Analyst Consensus and Anticipation for Reporting Date. Leo Pharma has entered an agreement for the acquisition of US-based clinical-stage biopharma firm Timber.

Related Results

November 22, 2023 21:18 (London Time)